Evidence map›Paper›PMID 39416869›Full record

ArticleFrontiers in medicine2024

A novel metastatic tumor segmentation method with a new evaluation metric in clinic study.

Bin Li, Qiushi Sun, Xianjin Fang, Yang Yang, Xiang Li

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bin Li *Department of Neurology, The First Hospital of Anhui University of Science and Technology, Huainan, China.
Qiushi Sun *Department of Anesthesiology, Fudan University Affiliated Huashan Hospital, Shanghai, China.
Xianjin FangDepartment of Anesthesiology, Fudan University Affiliated Huashan Hospital, Huainan, China.
Yang YangDepartment of Anesthesiology, Fudan University Affiliated Huashan Hospital, Huainan, China.
Xiang LiDepartment of Anesthesiology, Fudan University Affiliated Huashan Hospital, Huainan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Brain metastases are the most common brain malignancies. Automatic detection and segmentation of brain metastases provide significant assistance for radiologists in discovering the location of the lesion and making accurate clinical decisions on brain tumor type for precise treatment. Objectives: However, due to the small size of the brain metastases, existing brain metastases segmentation produces unsatisfactory results and has not been evaluated on clinic datasets. Methodology: In this work, we propose a new metastasis segmentation method DRAU-Net, which integrates a new attention mechanism multi-branch weighted attention module and DResConv module, making the extraction of tumor boundaries more complete. To enhance the evaluation of both the segmentation quality and the number of targets, we propose a novel medical image segmentation evaluation metric: multi-objective segmentation integrity metric, which effectively improves the evaluation results on multiple brain metastases with small size. Results: Experimental results evaluated on the BraTS2023 dataset and collected clinical data show that the proposed method has achieved excellent performance with an average dice coefficient of 0.6858 and multi-objective segmentation integrity metric of 0.5582. Conclusion: Compared with other methods, our proposed method achieved the best performance in the task of segmenting metastatic tumors.

Indexed as

brain metastasesdeep learningmedical image segmentationmulti-objective segmentation integrity metricprecise treatment

Identifiers

PMID39416869
PMCPMC11479867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.